Addi Suleiman is a Cardiology physician affiliated with New York Medical College. OpenAlex indexes 102 publications with 219 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1340 Charles St Ste 300
Rockford, IL 611042200
Telephone
779-696-5888Provider last certified this registry record 15 May 2026.
Industry payments
24 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABIOMEDProgram year20256 payments
- Abbott LaboratoriesProgram year20256 payments
- Medtronic, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
73.7%Beta blocker18.6%Metoprolol Succinate72%Carvedilol19%Metoprolol Tartrate9%Part D≥140 patientsStatin12.7%Atorvastatin Calcium79%Rosuvastatin Calcium17%Simvastatin5%Part D<11 patients+ 13 more classes in this area
Blood & clotting
14.2%Factor Xa inhibitor8%Eliquis89%Xarelto11%Part D<11 patientsP2Y12 inhibitor5.2%Clopidogrel84%Brilinta16%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
6.3%SGLT2 inhibitor2.8%Jardiance63%Farxiga38%Part D<11 patientsProton pump inhibitor1.6%Pantoprazole Sodium68%Omeprazole32%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 26-A-19410-ACC PALLIATIVE CARE UTILIZATION AND OUTCOMES AMONG HEART FAILURE PATIENTS RECEIVING MECHANICAL CIRCULATORY SUPPORT: INSIGHTS FROM THE 2022 NATIONAL INPATIENT SAMPLE (NIS)
Journal of the American College of Cardiology
2026 - DOUBLE EDGED SWORD: CAN LIFE SAVING AND LESS RESISTANT CANCER TREATMENT, THIRD GENERATION TYROSINE KINASE INHIBITORS ALSO RAPIDLY ACCELERATE THE PROGRESSION OF AORTIC STENOSIS?
Journal of the American College of Cardiology
2025 - SEE-SAW IN THE HIS-PURKINJE SYSTEM: PEMBROLIZUMAB INDUCED MYOCARDITIS DISGUISED AS BIDIRECTIONAL VENTRICULAR TACHYCARDIA
Journal of the American College of Cardiology
2025 - A RARE CASE OF TYPE 4 SCAD: A MISDIAGNOSED CAUSE OF ACUTE CORONARY SYNDROME
Journal of the American College of Cardiology
2025 - Trends and Disparities in Valvular Heart Disease Mortality in the United States From 1999 to 2020
Journal of the American Heart Association
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Mitchell Cairo, MD
New York Medical College
Leslie Citrome, MD, MPH
New York Medical College
Jihad Slim, MD
New York Medical College
Gary Wormser, MD
New York Medical College
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”